博睿数据(688229.SH)首次公开发行1110万股 发行价65.82元/股 8月5日申购
格隆汇8月3日丨博睿数据(688229.SH)公布,公司本次公开发行新股的数量为1110万股,占发行后公司总股本的25.00%,本次公开发行后公司总股本为4440万股。发行价格为65.82元/股。
发行人证券简称为“博睿数据”,证券扩位简称为“博睿宏远数据”,证券代码为688229,该代码同时用于本次发行的初步询价及网下申购。本次发行网上申购代码为787229。
本次网下发行申购日与网上申购日同为2020年8月5日(T日),其中,网下申购时间为9:30~15:00,网上申购时间为9:30~11:30,13:00~15:00。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.